In Vitro Study of the Role of Factor IX in Treatment of Breakthrough Bleeds in Patients with Hemophilia A and Inhibitors Receiving Emicizumab.

TH Open · 2026 · PMC13189426 · PMID 42169751

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Likewise, rFVIIa at 6.75 μg/mL produced a highly significant increase ( p < 0.0001), further supporting its strong procoagulant effect under these assay conditions.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.